GlassScriptPhysician profile
Roosha Parikh
NPI 1043560626
$72,780.68
in general payments reported to CMS, 2019-2025
14 companies · $56K in 2025
The $56K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $972 · 2020: $253 · 2022: $809 · 2023: $2,456 · 2024: $12K · 2025: $56K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $59K · Travel and Lodging: $7,315 · Food and Beverage: $3,087 · Consulting Fee: $1,805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $58,540.00 |
| Travel and Lodging | $7,315.10 |
| Food and Beverage | $3,086.97 |
| Consulting Fee | $1,805.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $67,860.86 | 2022-2025 | Ffrct |
| Siemens Medical Solutions USA, INC. | $1,737.06 | 2023 | Naeotom Alpha |
| Medtronic, INC. | $916.44 | 2022-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Boston Scientific Corporation | $757.73 | 2019-2023 | |
| Amgen INC. | $488.00 | 2019-2020 | |
| Abbott Laboratories | $315.47 | 2022-2025 | Triclip, Optis, Mitraclip |
| Cleerly, INC. | $161.87 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Edwards Lifesciences Corporation | $113.97 | 2020-2025 | Sapien 3 Ultra Resilia |
| Philips North America LLC | $110.84 | 2025 | Igt Devices Undivided |
| Recor Medical INC | $107.89 | 2025 | Paradise Ultrasound Renal Denervation System |
| Lantheus Medical Imaging, INC. | $82.00 | 2020-2025 | Definity |
| Pfizer INC. | $72.84 | 2020 | |
| Medtronic Vascular, INC. | $39.22 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $16.49 | 2023 | Caldolor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roosha Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.